Prospective cohort study examines viremia trends in pregnant and postpartum AGYW, suggesting need for tailored interventions.
Abstract Objective This large cohort study examines long-term trends and predictors of viremia among pregnant and postpartum adolescent girls and young women (AGYW) living with HIV in Tanzania. Methods This prospective cohort study included 7,703 pregnant/postpartum AGYW with at least one viral load (VL) enrolled in routine PMTCT care between 2018 and 2020 across three regions in Tanzania and followed for a minimum of 36 months. Poisson generalized Linear Models (log link) estimated adjusted incident rate ratios (aIRRs) and 95% confidence intervals (CIs) for detectable viremia (VL≥50 copies/mL) by baseline exposures. Results Over three years, detectable viremia was higher among the youngest aged 15-17 (20·4%), compared to 18–19 years (16·7%) and 20–24 years (12·5%). Viremia declined during pregnancy but plateaued postpartum, with over 10% remaining viremic. Perinatally infected AGYW (HIV diagnosis before ≤12 years) had higher viremia (28·8%) than those on ART (11·0%) and new on ART (15·2%) who were diagnosed after childhood. Over 25% of perinatally infected AGYW remained viremic throughout the PMTCT cycle. Second-line ART and urban residence were associated with higher risk of viremia. Conclusion Persistently high viremia was observed over time among Tanzanian pregnant/postpartum AGYW with HIV, particularly among adolescents and those with perinatally acquired infection. Tailored PMTCT interventions, including resistance-informed treatment and youth-friendly adherence support, are needed to improve maternal outcomes and accelerate elimination of vertical transmission.
No takes yet. Share an insight, caveat, or question.
Urrio et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: